![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/451 | |
A61P 25/28 | |||
A61K 31/00 | |||
A61P 25/22 | |||
A61P 25/24 | |||
A61P 25/14 | |||
A61P 25/00 |
(11) | Number of the document | 3010506 |
(13) | Kind of document | T |
(96) | European patent application number | 14813621.1 |
Date of filing the European patent application | 2014-06-19 | |
(97) | Date of publication of the European application | 2016-04-27 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/043204 |
Date | 2014-06-19 |
(87) | Number | WO 2014/205229 |
Date | 2014-12-24 |
(30) | Number | Date | Country code |
201361837928 P | 2013-06-21 | US | |
201361877832 P | 2013-09-13 | US |
(72) |
BASSAN, Merav, IL
EYAL, Eli, IL
HAGAI, Esther, Lukasiewicz, IL
SVEINSDOTTER TEIGE WICKENBERG, Anna, Kristina, SE
|
(73) |
Prilenia Neurotherapeutics Ltd.,
10 HaMenofim Street, Herzliya 4672561,
IL
|
(54) | PRIDOPIDINE IN TREATING HUNTINGTON`S DISEASE |
PRIDOPIDINE IN TREATING HUNTINGTON`S DISEASE |